Literature DB >> 16420750

Genetic regulation of host responses to group A streptococcus in mice.

Eva Medina1, Andreas Lengeling.   

Abstract

The group A streptococci (GAS, Streptococcus pyogenes) are important human pathogens which can cause a variety of diseases, ranging from mild infections to very severe invasive diseases. In recent years, evidence has been accumulated that host genetic factors have a major influence on the outcome of streptococcal infections. Variability in the degree of susceptibility of different inbred mouse strains to infection with GAS has demonstrated that the host genetic background largely determines the susceptibility of mice to this pathogen. This information is particularly useful for studying the immune mechanisms underlying disease susceptibility in mice, and provides an entry point for the identification of host defence loci. This paper reviews the recent advances in the characterisation of pathogenic mechanisms associated with the development of GAS-induced septic shock in the mouse model and outlines the current knowledge regarding the genetic control of immune responses to Group A streptococcus in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16420750     DOI: 10.1093/bfgp/4.3.248

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  12 in total

1.  The fruRBA Operon Is Necessary for Group A Streptococcal Growth in Fructose and for Resistance to Neutrophil Killing during Growth in Whole Human Blood.

Authors:  Kayla M Valdes; Ganesh S Sundar; Luis A Vega; Ashton T Belew; Emrul Islam; Rachel Binet; Najib M El-Sayed; Yoann Le Breton; Kevin S McIver
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 2.  Postpartum group a Streptococcus sepsis and maternal immunology.

Authors:  Katie L Mason; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2011-10-24       Impact factor: 3.886

3.  Host Genetic Variations and Sex Differences Potentiate Predisposition, Severity, and Outcomes of Group A Streptococcus-Mediated Necrotizing Soft Tissue Infections.

Authors:  Karthickeyan Chella Krishnan; Santhosh Mukundan; Jeyashree Alagarsamy; Donna Laturnus; Malak Kotb
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

4.  The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.

Authors:  Hong Sjölinder; Lena Lövkvist; Laura Plant; Jens Eriksson; Helena Aro; Allison Jones; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

5.  Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Danuta Radzioch; Serge Rivest; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

6.  A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.

Authors:  Aniela Wozniak; Patricia García; Enrique A Geoffroy; Daniel B Aguirre; Samantha A González; Victoria A Sarno; James B Dale; Francisco J Salazar-Echegarai; Andrea Vera; Susan M Bueno; Alexis M Kalergis
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

7.  Genetic susceptibility to non-necrotizing erysipelas/cellulitis.

Authors:  Katariina Hannula-Jouppi; Satu Massinen; Tuula Siljander; Siru Mäkelä; Katja Kivinen; Rasko Leinonen; Hong Jiao; Päivi Aitos; Matti Karppelin; Jaana Vuopio; Jaana Syrjänen; Juha Kere
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2.

Authors:  Christina Fieber; Marton Janos; Tina Koestler; Nina Gratz; Xiao-Dong Li; Virginia Castiglia; Marion Aberle; Martina Sauert; Mareike Wegner; Lena Alexopoulou; Carsten J Kirschning; Zhijian J Chen; Arndt von Haeseler; Pavel Kovarik
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

9.  Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors.

Authors:  David Ermert; Jutamas Shaughnessy; Thorsten Joeris; Jakub Kaplan; Catherine J Pang; Evelyn A Kurt-Jones; Peter A Rice; Sanjay Ram; Anna M Blom
Journal:  PLoS Pathog       Date:  2015-07-22       Impact factor: 6.823

10.  Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9.

Authors:  Nina Gratz; Maria Siller; Barbara Schaljo; Zaid A Pirzada; Irene Gattermeier; Ivo Vojtek; Carsten J Kirschning; Hermann Wagner; Shizuo Akira; Emmanuelle Charpentier; Pavel Kovarik
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.